KINETICS OF ATRIAL-NATRIURETIC-PEPTIDE IN YOUNG AND ELDERLY SUBJECTS

被引:0
作者
TAN, ACITL
JANSEN, TLTA
TERMOND, EFS
RUSSEL, FGM
THIEN, T
KLOPPENBORG, PWC
BENRAAD, TJ
机构
[1] CATHOLIC UNIV NIJMEGEN,ST RADBOUD HOSP,DEPT MED,DIV GEN INTERNAL MED,POB 9101,6500 HB NIJMEGEN,NETHERLANDS
[2] CATHOLIC UNIV NIJMEGEN,ST RADBOUD HOSP,DEPT EXPTL & CHEM ENDOCRINOL,DIV CLIN PHARM,6500 HB NIJMEGEN,NETHERLANDS
[3] CATHOLIC UNIV NIJMEGEN,ST RADBOUD HOSP,DIV PHARMACOL,6500 HB NIJMEGEN,NETHERLANDS
[4] CATHOLIC UNIV NIJMEGEN,ST RADBOUD HOSP,DIV ENDOCRINOL,6500 HB NIJMEGEN,NETHERLANDS
关键词
ATRIAL NATRIURETIC PEPTIDE; KINETICS; AGING;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To study the influence of age on the kinetics of atrial natriuretic peptide (ANP) in man, human (99-126)ANP 2.0-mu-g.min-1 was infused IV for 60 min in 8 healthy young (18 to 25 y) and 9 healthy elderly (71 to 84 y) subjects. Both baseline ANP values and the levels at the end of infusion were higher in the elderly subjects. The mean residence time of ANP in the two age groups was not significantly different, whereas total body clearance (CL) was markedly diminished in the elderly as compared to the young subjects (mean +/- SD 3.1 +/- 1.01.min-1 and 6.2 +/- 4.1 l.min-1, respectively). The apparent volume of distribution at steady state was lower in the elderly than in the young, but the difference was not significant (mean +/- SD 44 +/- 19 and 103 +/- 111, respectively. The decrease in CL largely explained the higher ANP levels found in the elderly subjects. The MRT and the plasma half-life of the terminal phase did not differ between the two groups. In the elderly but not in the young subjects the calculated endogenous creatinine clearance was closely correlated with the CL (r = 0.90, P < 0.001), thereby emphasizing the importance of the kidney in the metabolic clearance of ANP in the elderly.
引用
收藏
页码:449 / 452
页数:4
相关论文
共 26 条
[11]   CLEARANCE OF ATRIAL NATRIURETIC FACTOR BY LUNG, LIVER, AND KIDNEY IN HUMAN-SUBJECTS AND THE DOG [J].
HOLLISTER, AS ;
RODEHEFFER, RJ ;
WHITE, FJ ;
POTTS, JR ;
IMADA, T ;
INAGAMI, T .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (02) :623-628
[12]   HEMODYNAMIC-EFFECTS OF ATRIAL-NATRIURETIC-FACTOR IN YOUNG AND ELDERLY SUBJECTS [J].
JANSEN, TLTA ;
TAN, ACITL ;
SMITS, P ;
DEBOO, T ;
BENRAAD, TJ ;
THIEN, T .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (02) :179-188
[13]   ATRIAL-NATRIURETIC-PEPTIDE - A NEW FACTOR IN BLOOD-PRESSURE CONTROL [J].
LANG, RE ;
UNGER, T ;
GANTEN, D .
JOURNAL OF HYPERTENSION, 1987, 5 (03) :255-271
[14]  
LUFT FC, 1986, J PHARMACOL EXP THER, V236, P416
[15]   PHYSIOLOGICAL-ROLE OF SILENT RECEPTORS OF ATRIAL-NATRIURETIC-FACTOR [J].
MAACK, T ;
SUZUKI, M ;
ALMEIDA, FA ;
NUSSENZVEIG, D ;
SCARBOROUGH, RM ;
MCENROE, GA ;
LEWICKI, JA .
SCIENCE, 1987, 238 (4827) :675-678
[16]   A HIGHLY SENSITIVE RADIOIMMUNOASSAY OF ATRIAL-NATRIURETIC-PEPTIDE (ANP) IN HUMAN-PLASMA AND URINE [J].
MARUMO, F ;
SAKAMOTO, H ;
ANDO, K ;
ISHIGAMI, T ;
KAWAKAMI, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 137 (01) :231-236
[17]   SIMPLIFIED CALCULATION OF BODY-SURFACE AREA [J].
MOSTELLER, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (17) :1098-1098
[18]   THE PHARMACOKINETICS OF ALPHA-HUMAN ATRIAL NATRIURETIC POLYPEPTIDE IN HEALTHY-SUBJECTS [J].
NAKAO, K ;
SUGAWARA, A ;
MORII, N ;
SAKAMOTO, M ;
YAMADA, T ;
ITOH, H ;
SHIONO, S ;
SAITO, Y ;
NISHIMURA, K ;
BAN, T ;
KANGAWA, K ;
MATSUO, H ;
IMURA, H .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (01) :101-103
[19]   PHARMACOKINETICS OF SYNTHETIC ALPHA-HUMAN ATRIAL NATRIURETIC POLYPEPTIDE IN NORMAL MEN - EFFECT OF AGING [J].
OHASHI, M ;
FUJIO, N ;
NAWATA, H ;
KATO, K ;
MATSUO, H ;
IBAYASHI, H .
REGULATORY PEPTIDES, 1987, 19 (5-6) :265-272
[20]   THE INTERNATIONAL STANDARD FOR ATRIAL NATRIURETIC FACTOR - CALIBRATION BY AN INTERNATIONAL COLLABORATIVE STUDY [J].
POOLE, S ;
DAS, REG ;
DZAU, VJ ;
RICHARDS, AM ;
ROBERTSON, JIS .
HYPERTENSION, 1988, 12 (06) :629-634